| abstract |
The invention concerns the use of compounds of formula (I), (II) and (III): n nwhich are COX-2 (cyclooxygenase-2) inhibitors, and pharmaceutically acceptable salts or solvates thereof, for the treatment of depressive disorders in combination with an effective amount of a second component which is a selective serotonin reuptake inhibitor. |